Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925)

Matzinger, Oscar; Heimsoth, Irma; Poortmans, Philip; Collette, Laurence; Struikmans, Henk; Van Den Bogaert, Walter; Fourquet, Alain; Bartelink, Harry; Ataman, Fatma; Gulyban, Akos; Pierart, Marianne; Van Tienhoven, Geertjan

doi:10.3109/02841860903352959

Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925)

Copy For Citation

Matzinger O., Heimsoth I., Poortmans P., Collette L., Struikmans H., Van Den Bogaert W., ...More

ACTA ONCOLOGICA, vol.49, no.1, pp.24-34, 2010 (SCI-Expanded)

Publication Type: Article / Article
Volume: 49 Issue: 1
Publication Date: 2010
Doi Number: 10.3109/02841860903352959
Journal Name: ACTA ONCOLOGICA
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.24-34
Süleyman Demirel University Affiliated: Yes

Abstract

Introduction. The EORTC 22922/10925 trial investigated the potential survival benefit and toxicity of elective irradiation of the internal mammary and medial supraclavicular (IM-MS) nodes Accrual completed in January 2004 and first results are expected in 2012. We present the toxicity reported until year 3 after treatment.